María Pilar
Garrido López
Profesor/a Asociado/a en CC. de la Salud
Fondazione IRCCS Istituto Nazionale dei Tumori
Milán, ItaliaPublicacions en col·laboració amb investigadors/es de Fondazione IRCCS Istituto Nazionale dei Tumori (6)
2022
-
A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry
Journal of Thoracic Oncology, Vol. 17, Núm. 5, pp. 661-674
2021
-
Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey
ESMO Open, Vol. 6, Núm. 3, pp. 1-7
2020
-
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
The Lancet Oncology, Vol. 21, Núm. 7, pp. 914-922
-
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus
Annals of Oncology, Vol. 31, Núm. 10, pp. 1320-1335
2019
-
Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the committee for medicinal products for human use (chmp)
Annals of Oncology
-
Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer
European Journal of Cancer, Vol. 108, pp. 120-128